Elite Pharmaceuticals Inc (ELTP)
0.6168
0.00 (0.00%)
USD |
OTCM |
Nov 22, 16:00
Elite Pharmaceuticals Cash from Operations (Quarterly): 1.457M for Sept. 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.457M |
| June 30, 2024 | 3.144M |
| March 31, 2024 | 2.06M |
| December 31, 2023 | -2.396M |
| September 30, 2023 | -0.2359M |
| June 30, 2023 | -2.710M |
| March 31, 2023 | 2.969M |
| December 31, 2022 | -0.5679M |
| September 30, 2022 | 1.495M |
| June 30, 2022 | -0.5575M |
| March 31, 2022 | 1.605M |
| December 31, 2021 | 3.034M |
| September 30, 2021 | 0.1538M |
| June 30, 2021 | 1.716M |
| March 31, 2021 | -0.7494M |
| December 31, 2020 | 1.235M |
| September 30, 2020 | 1.900M |
| June 30, 2020 | 0.8074M |
| March 31, 2020 | -1.206M |
| December 31, 2019 | -0.3122M |
| September 30, 2019 | -0.4638M |
| June 30, 2019 | 0.1883M |
| March 31, 2019 | -2.136M |
| December 31, 2018 | -1.268M |
| September 30, 2018 | -1.679M |
| Date | Value |
|---|---|
| June 30, 2018 | -1.710M |
| March 31, 2018 | -1.014M |
| December 31, 2017 | -0.4781M |
| September 30, 2017 | -2.226M |
| June 30, 2017 | -1.091M |
| March 31, 2017 | -4.076M |
| December 31, 2016 | -0.7264M |
| September 30, 2016 | -2.317M |
| June 30, 2016 | -0.7642M |
| March 31, 2016 | 0.6064M |
| December 31, 2015 | -1.784M |
| September 30, 2015 | -3.479M |
| June 30, 2015 | 1.891M |
| March 31, 2015 | -3.856M |
| December 31, 2014 | -2.606M |
| September 30, 2014 | -4.428M |
| June 30, 2014 | -4.213M |
| March 31, 2014 | -1.475M |
| December 31, 2013 | -1.457M |
| September 30, 2013 | -0.9297M |
| June 30, 2013 | -0.355M |
| March 31, 2013 | -0.2267M |
| December 31, 2012 | -0.3269M |
| September 30, 2012 | -0.8424M |
| June 30, 2012 | -0.2974M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-2.710M
Minimum
Jun 2023
3.144M
Maximum
Jun 2024
0.6421M
Average
1.021M
Median
Cash from Operations (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 221.48M |
| BioCardia Inc | -2.611M |
| Zevra Therapeutics Inc | -18.14M |
| Verrica Pharmaceuticals Inc | -8.558M |
| Terns Pharmaceuticals Inc | -16.46M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0176M |
| Cash from Financing (Quarterly) | -0.3207M |
| Free Cash Flow | 1.685M |
| Free Cash Flow Per Share (Quarterly) | 0.0013 |
| Free Cash Flow to Equity (Quarterly) | 1.595M |
| Free Cash Flow to Firm (Quarterly) | 1.653M |
| Free Cash Flow Yield | 0.26% |